kitUP Originals
Matthew Walker exposes a decades-long clinical blind spot: insomnia was labelled "secondary" and left untreated, assumed to vanish once depression lifted. Prospective studies reversed the arrow. The 1989 landmark trial and two independent meta-analyses showed that persistent sleep complaints doubled the risk of later depression in people whose mood was fine at baseline. Trials pooling over sixty interventions revealed a dose-response chain: the more sleep improved, the more mood followed. Yet the effect is moderate, and heritability data suggest the arrow runs both ways.
You'll learn:
- Why the "secondary insomnia" label delayed treatment for years
- How dose-response patterns distinguish causation from coincidence
- What studies in communities without electricity reveal about the eight-hour myth
Join a learning community of over 37 million people. Fill your daily routine with the world's best ideas.
Get Started